Private company
Cardiovascular Systems Inc
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
73.1%Gross margin2
-15.2%Operating margin2
-15.6%Net margin2
-8.8%Revenue growth, 20222
-14.8%Return on equity2
-$28.5MFree cash flow2
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue23¢$63.4M
- Research and development13¢$36.7M
- Selling, general and admin63¢$170.5M
- Interest1¢$1.6M
- Income tax0¢$310.0K
Out of $236.2M in revenue.2 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $181.5M4 | $178.2M5 | $204.9M6 | $217.0M7 | $248.0M8 | $236.5M2 | $259.0M2 | $236.2M2 |
| Cost of revenue | $39.5M4 | $35.4M5 | $39.4M6 | $39.5M7 | $47.7M8 | $48.8M2 | $61.1M2 | $63.4M2 |
| Gross profit | $142.0M4 | $142.8M5 | $165.5M6 | $177.6M7 | $200.3M8 | $187.8M2 | $197.8M2 | $172.8M2 |
| Research and development | $31.0M4 | $25.9M5 | $22.9M6 | $26.6M7 | $33.2M8 | $43.4M2 | $41.1M2 | $36.7M2 |
| Selling, general and admin | $143.7M4 | $162.5M5 | $144.1M6 | $148.6M7 | $167.7M8 | $170.0M2 | $167.5M2 | $170.5M2 |
| Operating income | -$32.6M4 | -$56.1M5 | -$1.5M6 | $2.2M7 | -$825.0K8 | -$26.8M2 | -$11.9M2 | -$35.8M2 |
| Interest | $23.0K4 | $05 | $500.0K6 | $1.7M7 | $1.7M8 | $2.0M2 | $1.7M2 | $1.6M2 |
| Income tax | $114.0K4 | $92.0K5 | $86.0K6 | $132.0K7 | $190.0K8 | $231.0K2 | $252.0K2 | $310.0K2 |
| Net income | -$32.8M4 | -$56.0M5 | -$1.8M6 | $1.7M7 | -$255.0K8 | -$27.2M2 | -$13.4M2 | -$36.9M2 |
| Earnings per share | -$1.725 | -$0.066 | $0.057 | -$0.017 | -$0.792 | -$0.352 | -$0.942 | |
| Earnings per share (diluted) | -$1.725 | -$0.066 | $0.057 | -$0.017 | -$0.792 | -$0.352 | -$0.942 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash | $83.8M5 | $60.6M6 | $107.9M7 | $116.3M8 | $74.2M8 | $185.5M8 | $71.1M2 | $66.4M2 |
| Current assets | $133.9M10 | $104.9M4 | $159.1M5 | $167.6M6 | $180.1M7 | $287.7M8 | $284.7M2 | $241.8M2 |
| Total assets | $171.3M10 | $142.4M4 | $193.9M5 | $203.4M6 | $218.6M7 | $339.5M8 | $352.6M2 | $322.7M2 |
| Current liabilities | $29.9M10 | $35.5M4 | $41.0M5 | $37.5M6 | $42.3M7 | $44.5M8 | $54.6M2 | $40.0M2 |
| Total liabilities | $31.9M10 | $41.5M4 | $75.6M5 | $68.9M6 | $70.6M7 | $70.7M8 | $81.6M2 | $73.2M2 |
| Shareholders’ equity | $139.4M5 | $100.9M6 | $118.4M7 | $134.5M8 | $147.9M2 | $268.8M2 | $271.0M2 | $249.5M2 |
| Shares outstanding | 32.5M shares11 | 33.3M shares10 | 33.0M shares4 | 33.5M shares5 | 35.3M shares6 | 39.7M shares7 | 40.2M shares8 | 41.0M shares2 |
Former names
- REPLIDYNE INCAug 12, 2002 to Mar 3, 20093
Recent filings
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Apr 27, 20238-K
- Apr 13, 20238-K
- Feb 14, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Feb 14, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11